|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.880 USD | +25.76% |
|
+50.00% | -57.01% |
| 11/09/25 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 01/04/25 | GRI Bio Prices up to $13 Million Equity Offering | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GRI | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 7.02 | 8.733 | 8.136 |
| Spread/Res. | -58.97% | -67.02% | -64.60% |
| Spread/Supp. | +37.35% | +37.35% | +1.13% |
| Support | 2.097 | 2.097 | 2.848 |
- Stock Market
- Stocks
- GRI Stock
- Charts GRI BIOPAR
Select your edition
All financial news and data tailored to specific country editions
